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Gilbert and Crigler–Najjar syndromes are familial unconjugated hyperbilirubinemias caused by genetic lesions involving a single complex locus
encoding for bilirubin UDP-glucuronosyltransferase (UGT1A1) gene. Over the last years, a number of different mutations affecting this gene have
been characterized. In this report is provided a summary of reported Gilbert and Crigler–Najjar syndromes-associated UGT1A1 gene mutations.
D 2005 Elsevier Inc. All rights reserved.Keywords: Gilbert syndrome; UGT1A1; Hyperbilirubinemia; MutationsWater-insoluble bilirubin, which results from breakdown
products of heme, is a toxic compound. Hepatic glucuroniza-
tion of this insoluble bilirubin is catalyzed by isoenzyme 1A1
of UDP-glucuronosyltransferase (UGT1A1), which is essential
for efficient biliary excretion of bilirubin [1,2]. Mutations in the
UGT1A1 gene (UGT1A1; MIM#191740) are responsible for
both Gilbert and Crigler–Najjar syndromes. Genetic alterations
causing absence, or severe reduction, of UGT1A1 enzymatic
activity, result respectively in Crigler–Najjar syndrome type I
and type II [1–5]. The clinical classification of Crigler–Najjar
syndrome types I and II is based on the bilirubin levels, the
presence of kernictus and the reduction of the bilirubin levels
upon administration of phenobarbital or other enzyme-inducing
agents [3,4]. Type I Crigler–Najjar syndrome is characterized
by almost complete absence of UGT1A1 enzyme activity, with
serum bilirubin levels of 340–685 Amol/l or higher and is
refractory to phenobarbital treatment. In type II Crigler–Najjar
syndrome, enzyme activity is severely reduced, with a serum
bilirubin level of 100–340 Amol/l. Enzyme activity can be
induced by phenobarbital treatment [3,4]. Mild hyperbilirubi-
nemia, usually less than 50 Amol/l, is associated with Gilbert
Syndrome and thought to reflect a small reduction in UGT1A11079-9796/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
doi:10.1016/j.bcmd.2005.10.006
E-mail address: elisio.costa@ipb.pt.activity (approximately 30%) [2]. UGT1A1 protein is encoded
by five consecutive exons located at the 3V end of the UGT1A
locus [5].
Gilbert and Crigler–Najjar Syndromes gene mutations are
shown in Table 1. The nucleotide numbers shown in this table
are based on the cDNA sequence in the GenBank, accession
number NM_000463.2. The recommended numbering conven-
tion used in this tabulation assigns ‘‘1’’ to the A of the initiator
ATG codon. Mutations are described according to the
recommendations of the Human Genome Variation Society
(www.hgvs.org).
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c.3279T > G – Substitution GS [6,7] Described also associated with
c.41_40dupTA
c.41_40dupTA – Duplication GS [8] Described as (TA)7 allele.
The most common mutation
associated with GS in
Caucasian population.
Also associated with neonatal
hyperbilirubinemia
c.43_40dupTATA – Duplication GS [9] Described as (TA)8 allele
c.44T > G p.L15R Substitution CN2 [10] b
c.101C > A p.P34Q Substitution CN2 [11] c
c.115C > G p.H39D Substitution CN1 [12] d
c.145C > T p.Q49X Substitution CN1 [13] c
c.211G > A p.G71R Substitution SG [14] The most common mutation
associated with GS in Asian
population. Also associated
with neonatal hyperbilirubinemia
c.222C > A p.Y74X Substitution CN1 [12] d
c.247T > C p.F83L Substitution GS [15] Homozygosity was described in
association with GS
c.357_358delCT p. S120CfsX25 Deletion, frameshift CN1 [16] d
c.488_491dupACCT p.S165PfsX18 Duplication, frameshift GS [17] Described in trans with
c. 41_ 40dupTA mutation
c.508_510delTTC p.F170del Deletion CN2 [18] d
c.517delC p.H173MfsX31 Deletion, frameshift CN1 [12] d
c.524T > A p.L175Q Substitution CN2 [19] c
c.529T > C p.C177R Substitution CN1 [19] c
c.576C > G p.Y192X Substitution CN1, CN2 [11] This mutation in trans with
c.1184G > T mutation was
associated with CN1 and
in trans with c.1130G > T
mutation was associated with CN2
c.625C > T p.R209W Substitution CN2 [20] b
c.674T > G p.V225G Substitution CN2 [21,17] Also associated with GS in cis
with c. 41_ 40dupTA mutation
c.686C > A p.P229Q Substitution GS [22] Detected in heterozygosity
c.717_718delAG p.E241GfsX15 Deletion, frameshift CN2 [21] Described in association with
two other mutations
c.801delC p.I268SfsX97 Deletion, frameshift CN1 [11] d
c.835A > T p.N279Y Substitution CN1 [19] c
c.840C > A p.C280X Substitution CN1 [23] d
c.864 + 1G > C Splicing alteration Substitution frameshift CN1 [13] d
c.865  ?_997 + ?del p. E288_T332del Deletion CN1 [19] Alteration detected only
at RNA level
c.865  1G > A Splicing alteration Substitution frameshift CN1 [11] c
c.875C > T p.A292V Substitution CN1 [24] c
[c.877T > A + c.878_890del] p.I294_S297delY293MfsX68 Substitution, deletion, frameshift CN2 [11,25] d
c.878_890del p.I294_S297delY293LfsX68 Deletion, frameshift CN2 [11,25] c
c.881T > C p.I294T Substitution CN2 [26] c
c.923G > A p.G308E Substitution CN1 [27,17] Also associated with GS and
CN2 in trans with
c. 41_ 40dupTA mutation
c.973delG p.A325LfsX40 Deletion, frameshift CN2 [19] c
c.991C > T p.Q331X Substitution CN1 [28] d
c.992A > G p.Q331R Substitution CN2 [29] b
c.997  2A > G Splicing alteration Substitution frameshift CN1 [25] c
c.1005G > A p.W335X Substitution CN1 [24] c
c.1006C > T p.R336W Substitution CN1 [26] c
c.1007G > A p.R336Q Substitution CN1 [11] c
c.1021C > T p.R341X Substitution CN1 [30] d
c.1043delA p.N348TfsX17 Deletion, frameshift CN1 [12] d
c.1060T > C p.W354T Substitution CN2 [11] c
c.1069C > T p.Q357X Substitution CN1 [24] d








c.1070A > G p.Q357R Substitution CN1 [24] d
c.1085  1G > A Splicing alteration Substitution CN1 [25] c
c.1099C > G p.R367G Substitution GS [22] Detected in heterozygosity
c.1102G > A p.A368T Substitution CN1 [24] c
c.1124C > T p.S375F Substitution CN1 [27] d
c.1127A > G p.H376R Substitution CN2 [12] c
c.1130G > T p.G377V Substitution CN2 [12] d
c.1143C > G p.S381R Substitution CN1 [24] d
c.1157_1158indelsGT p.V386G Insertion, deletion CN1 [16] d
c.1159C > T p.P387S Substitution CN1 [11] c
c.1184G > T p.G395V Substitution CN1 [11] d
c.1186delG p.D396IfsX15 Deletion, frameshift CN2 [31] c
c.1198A > G p.N400D Substitution CN2 [32] Associated with homozygosity
for the c. 43_ 40dupTATA
mutation
c.1201G > C p.A401P Substitution CN1 [24] c
c.1207C > T p.R403C Substitution CN2 [11] c
c.1220delA p.K407RfsX4 Deletion, frameshift CN1 [12] c
c.1223insG p.A409SfsX12 Insertion, frameshift CN1 [24] c
c.1282A > G p.K428E Substitution CN1 [24] c
c.1304 + 1G > T Splicing alteration Substitution CN1 [11] c
c.1309A > T p.K437X Substitution CN1 [24] c
c.1381T > C p.W461R Substitution CN1 [33] d
c.1388A > C p.E463A Substitution CN2 [34] Associated with homozygosity
for the c. 41_ 40dupTA
mutation
c.1433C > A p.A478D Substitution CN2 [11] b
c.1448G > A p.W483X Substitution CN1 [12] d
c.1449G > A p.W483X Substitution CN1 [12] d
c.1456T > G p.Y486D Substitution CN2 [35] Associated with homozygosity
to the c.211G > A mutation
c.1463C > T p.S488F Substitution CN1 [28] d
c.1487T > A p.L496X Substitution CN1 [12] c
b) Homozygosity for this mutation was described in association with CN2.
c) This mutation was described in trans with other mutation.
d) Homozygosity for this mutation was described in association with CN1.
GS: Gilbert syndrome. CN1: Crigler–Najjar Syndrome type I. CN2: Crigler–Najjar Syndrome type II.
a The phenotype associated is related with the first description of the mutation.
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